Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 04, 2024 20:40 ET | Source: Robbins LLP

VERV REMINDER – Robbins LLP Urges VERV Investors to Obtain Legal Counsel in Light of the Pending Lead Plaintiff Deadline

Robbins LLP is Investigating Allegations that Verve Therapeutics, Inc. (VERV) Misled Investors Regarding its Clinical Trial
September 17, 2024 18:31 ET | Source: Robbins LLP

VERV CLASS ACTION: Verve Therapeutics, Inc. Stockholders Should Contact Robbins LLP for Information About the Securities Class Action Lawsuit

Robbins LLP is Investigating Allegations that Verve Therapeutics, Inc. (VERV) Misled Investors Regarding its Clinical Trial
September 04, 2024 18:36 ET | Source: Robbins LLP

VERV Class Action Notice: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Verve Therapeutics, Inc. Class Action

Robbins LLP is Investigating Allegations that Verve Therapeutics, Inc. (VERV) Misled Investors Regarding its Clinical Trial
August 28, 2024 17:09 ET | Source: Robbins LLP

Stockholder Notice: Robbins LLP Informs Stockholders of the Class Action Filed Against Verve Therapeutics, Inc.

Robbins LLP is Investigating Allegations that Verve Therapeutics, Inc. (VERV) Misled Investors Regarding its Clinical Trial